SEI Investments’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $59.9M | Buy |
1,249,186
+762,636
| +157% | +$32.8M | 0.05% | 390 |
|
|
2026
Q1 | $17.9M | Buy |
486,550
+169,906
| +54% | +$8.05M | 0.02% | 842 |
|
|
2025
Q4 | $16.1M | Buy |
316,644
+27,122
| +9% | +$1.39M | 0.02% | 845 |
|
|
2025
Q3 | $16.1M | Sell |
289,522
-125,247
| -30% | -$7.33M | 0.02% | 814 |
|
|
2025
Q2 | $28.6M | Sell |
414,769
-36,262
| -8% | -$2.47M | 0.03% | 546 |
|
|
2025
Q1 | $31.3M | Sell |
451,031
-189,418
| -30% | -$15.6M | 0.04% | 487 |
|
|
2024
Q4 | $55.1M | Sell |
640,449
-21,303
| -3% | -$2.3M | 0.07% | 293 |
|
|
2024
Q3 | $78.8M | Sell |
661,752
-57,032
| -8% | -$7.61M | 0.1% | 213 |
|
|
2024
Q2 | $103M | Sell |
718,784
-35,992
| -5% | -$4.77M | 0.15% | 138 |
|
|
2024
Q1 | $96.9M | Sell |
754,776
-52,662
| -7% | -$6.27M | 0.14% | 139 |
|
|
2023
Q4 | $83.5M | Buy |
807,438
+28,723
| +4% | +$2.84M | 0.13% | 147 |
|
|
2023
Q3 | $70.8M | Buy |
778,715
+296,449
| +61% | +$26.1M | 0.13% | 138 |
|
|
2023
Q2 | $39M | Buy |
482,266
+28,942
| +6% | +$2.36M | 0.07% | 304 |
|
|
2023
Q1 | $36.1M | Buy |
453,324
+10,364
| +2% | +$735K | 0.07% | 324 |
|
|
2022
Q4 | $30M | Buy |
442,960
+54,636
| +14% | +$3.2M | 0.07% | 333 |
|
|
2022
Q3 | $19.3M | Sell |
388,324
-28,180
| -7% | -$1.51M | 0.04% | 471 |
|
|
2022
Q2 | $23.1M | Buy |
416,504
+202,154
| +94% | +$11.2M | 0.05% | 416 |
|
|
2022
Q1 | $11.9M | Buy |
214,350
+31,992
| +18% | +$1.64M | 0.02% | 686 |
|
|
2021
Q4 | $10.2M | Sell |
182,358
-5,262
| -3% | -$285K | 0.02% | 784 |
|
|
2021
Q3 | $9.01M | Sell |
187,620
-35,980
| -16% | -$1.74M | 0.02% | 795 |
|
|
2021
Q2 | $9.37M | Buy |
223,600
+58,578
| +35% | +$2.27M | 0.02% | 769 |
|
|
2021
Q1 | $5.56M | Sell |
165,022
-38,938
| -19% | -$1.39M | 0.01% | 969 |
|
|
2020
Q4 | $7.12M | Sell |
203,960
-24,090
| -11% | -$833K | 0.02% | 799 |
|
|
2020
Q3 | $7.92M | Sell |
228,050
-54,378
| -19% | -$1.81M | 0.02% | 652 |
|
|
2020
Q2 | $9.25M | Sell |
282,428
-33,728
| -11% | -$1.08M | 0.03% | 578 |
|
|
2020
Q1 | $9.52M | Buy |
316,156
+1,606
| +0.5% | +$47.8K | 0.04% | 487 |
|
|
2019
Q4 | $9.1M | Sell |
314,550
-43,068
| -12% | -$1.19M | 0.03% | 623 |
|
|
2019
Q3 | $9.24M | Sell |
357,618
-20,682
| -5% | -$523K | 0.02% | 632 |
|
|
2019
Q2 | $9.65M | Sell |
378,300
-13,716
| -3% | -$339K | 0.03% | 598 |
|
|
2019
Q1 | $10.3M | Buy |
392,016
+332,914
| +563% | +$8.18M | 0.03% | 533 |
|
|
2018
Q4 | $1.39M | Buy |
59,102
+1,000
| +2% | +$22.2K | 0.01% | 1426 |
|
|
2018
Q3 | $1.37M | Sell |
58,102
-115,294
| -66% | -$2.81M | 0.01% | 1379 |
|
|
2018
Q2 | $4M | Sell |
173,396
-29,202
| -14% | -$694K | 0.01% | 1032 |
|
|
2018
Q1 | $4.99M | Buy |
202,598
+16,488
| +9% | +$433K | 0.02% | 817 |
|
|
2017
Q4 | $4.99M | Buy |
186,110
+149,092
| +403% | +$3.79M | 0.02% | 908 |
|
|
2017
Q3 | $891K | Buy |
37,018
+2,716
| +8% | +$61.4K | ﹤0.01% | 1486 |
|
|
2017
Q2 | $736K | Buy |
34,302
+15,156
| +79% | +$306K | ﹤0.01% | 1517 |
|
|
2017
Q1 | $328K | Sell |
19,146
-394
| -2% | -$6.86K | ﹤0.01% | 1671 |
|
|
2016
Q4 | $351K | Sell |
19,540
-553,578
| -97% | -$10M | ﹤0.01% | 1661 |
|
|
2016
Q3 | $11.9M | Sell |
573,118
-527,054
| -48% | -$13.1M | 0.06% | 395 |
|
|
2016
Q2 | $29.6M | Sell |
1,100,172
-55,552
| -5% | -$1.52M | 0.18% | 141 |
|
|
2016
Q1 | $31.3M | Sell |
1,155,724
-131,864
| -10% | -$3.53M | 0.19% | 127 |
|
|
2015
Q4 | $37.4M | Buy |
1,287,588
+963,872
| +298% | +$26.7M | 0.23% | 107 |
|
|
2015
Q3 | $8.78M | Buy |
323,716
+132,048
| +69% | +$3.74M | 0.08% | 280 |
|
|
2015
Q2 | $5.25M | Buy |
191,668
+2,862
| +2% | +$80.5K | 0.05% | 449 |
|
|
2015
Q1 | $5.04M | Sell |
188,806
-17,214
| -8% | -$396K | 0.04% | 460 |
|
|
2014
Q4 | $4.35M | Buy |
+206,020
| New | +$4.6M | 0.04% | 473 |
|
Other funds holding NVO
F
SEI Investments's NVO Position: Q2 2026 in Review
SEI Investments increased its Novo Nordisk (NVO) stake by 157% in Q2 2026, buying an estimated $32.8M and bringing the position to 1,249,186 shares worth $59.9M. The position accounts for 0.05% of the portfolio, ranked #390.
SEI Investments first reported a position in NVO in Q4 2014 and has held it in 47 quarters since. The position peaked at $103M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- SEI Investments held 1,249,186 shares of Novo Nordisk worth $59.9M as of Q2 2026.
- SEI Investments bought 762,636 Novo Nordisk shares in Q2 2026, an estimated $32.8M.
- Novo Nordisk made up 0.05% of SEI Investments's portfolio in Q2 2026, its #390 holding.
- SEI Investments first reported a position in Novo Nordisk in Q4 2014 and has held it in 47 quarters since.
- SEI Investments's Novo Nordisk position peaked at $103M in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.